STRING-DB analysis reveals protein-protein interactions central to mitochondrial electron transport and oxidative phosphorylation:
These interactions suggest recombinant gorilla HTATIP2 may influence cellular energy metabolism, analogous to its human homolog’s role in tumor suppression .
Silencing HTATIP2 in monocytes/macrophages enhances arteriogenic activity by upregulating Neuropilin-1 and Angiopoietin-1, promoting endothelial tubule formation and smooth muscle proliferation . In preclinical models, HTATIP2-silenced cells improved limb perfusion by 60%, highlighting its potential in treating ischemic diseases .
Studies in non-human primates (e.g., rhesus macaques) demonstrate conserved HTATIP2 expression networks with humans, enabling translational applications . For example, SHIV-infected macaques serve as proxies for HIV pathology, where HTATIP2 modulation could address immune dysregulation .
The NADPH-bound form of HTATIP2 acts as a redox sensor, inhibiting nuclear import of pro-survival factors under oxidative stress . Isoform-specific effects include:
Mechanistic Studies: Elucidate HTATIP2’s role in mitochondrial complex assembly using recombinant gorilla protein .
Therapeutic Targeting: Explore HTATIP2 inhibitors/activators for cancer or ischemic disorders, leveraging cross-species models .
Evolutionary Conservation: Investigate functional divergence between primate homologs to uncover adaptive mutations .
KEGG: ggo:101152326
STRING: 9593.ENSGGOP00000015311
HTATIP2 (HIV-1 Tat Interactive Protein 2) is a 242-amino acid oxidoreductase that functions primarily as a tumor suppressor. It demonstrates protein serine/threonine kinase activity and plays important roles in the regulation of nuclear import, angiogenesis, and programmed cell death . The protein exists in multiple isoforms with distinct functions: isoform 1 exhibits metastasis suppressor activity with proapoptotic and antiangiogenic properties, while isoform 2 demonstrates antiapoptotic effects . HTATIP2's NADPH-bound form competitively inhibits nuclear import by binding to nuclear transport receptors, suggesting its function as a redox sensor that links cellular redox status to transcriptional regulation through control of nuclear import mechanisms . Its involvement in positive regulation of programmed cell death and transcription by RNA polymerase II further emphasizes its importance in cellular homeostasis and cancer biology .
Gorilla HTATIP2 and human HTATIP2 share high sequence homology and conserved functional domains due to their close evolutionary relationship. STRING database analysis reveals that Gorilla HTATIP2 maintains the same core oxidoreductase function required for tumor suppression as its human counterpart . Both proteins act as redox sensors linked to transcription through regulation of nuclear import and compete with nuclear import substrates for binding to transport receptors . Western blot analysis using antibodies against human HTATIP2/TIP30 demonstrates cross-reactivity with the Gorilla protein, indicating conserved epitope regions between species . This conservation allows researchers to use findings from human HTATIP2 studies as a foundation for exploring Gorilla HTATIP2 function, while also investigating any species-specific variations that may exist in regulatory mechanisms or protein-protein interaction networks.
HTATIP2 demonstrates significant interactions with several mitochondrial proteins involved in electron transport and cellular respiration. According to STRING database analysis, its strongest predicted functional partners include NDUFS3 (NADH dehydrogenase [ubiquinone] iron-sulfur protein 3) with an interaction score of 0.902, NDUFS8 (NADH dehydrogenase [ubiquinone] iron-sulfur protein 8) scoring 0.892, and UQCRFS1 (Cytochrome b-c1 complex subunit Rieske) with a score of 0.889 . These interactions suggest HTATIP2 may play a role in mitochondrial function and energy metabolism beyond its established roles in tumor suppression. Co-immunoprecipitation studies have also demonstrated physical interactions between HTATIP2 and various signaling proteins, particularly those involved in cancer progression pathways . Understanding these protein-protein interactions is essential for elucidating the diverse cellular functions of HTATIP2 and its involvement in disease processes.
For recombinant Gorilla HTATIP2 expression, researchers must carefully select an expression system that preserves the protein's native folding and enzymatic activity. While prokaryotic systems like E. coli offer cost-effectiveness and high yields, the oxidoreductase activity and complex folding requirements of HTATIP2 often necessitate eukaryotic expression systems . Insect cell systems (particularly Sf9 or High Five cells) offer an excellent compromise, providing proper post-translational modifications while maintaining reasonable yields . For studies requiring fully glycosylated protein or investigating HTATIP2 isoforms, mammalian expression systems (HEK293 or CHO cells) are preferred despite their higher cost and lower yields . The expression system selection should be guided by the specific experimental requirements - structural studies may prioritize quantity and purity, while functional assays demand properly folded, active protein with native modifications. Regardless of the chosen system, codon optimization for Gorilla sequences is essential to maximize expression efficiency.
Purification of recombinant HTATIP2 requires a multi-step approach to maintain both purity and enzymatic activity. An effective purification strategy begins with affinity chromatography using either a His-tag (IMAC) or GST-tag system, depending on the expression construct . For HTATIP2 specifically, including 0.5-1 mM DTT or 2-mercaptoethanol in all purification buffers helps preserve the redox-sensitive active site . Following initial capture, size exclusion chromatography effectively separates HTATIP2 monomers (28 kDa) from dimeric forms (56 kDa) and other contaminants . For applications requiring exceptional purity, an ion exchange chromatography step (typically Q-Sepharose at pH 7.5-8.0) further removes endotoxins and nucleic acid contaminants. Quality control should include SDS-PAGE, western blot confirmation using anti-HTATIP2 antibodies, and enzymatic activity assays measuring NADPH oxidation . Researchers should be aware that HTATIP2 exhibits some instability during freeze-thaw cycles, necessitating the addition of 10% glycerol to storage buffers and aliquoting to minimize repeated freezing.
Verifying the functional activity of purified recombinant HTATIP2 requires assessing both its oxidoreductase activity and its ability to modulate nuclear import. For oxidoreductase activity, spectrophotometric assays measuring NADPH consumption (monitoring absorbance decrease at 340 nm) in the presence of suitable electron acceptors provide quantitative assessment of enzymatic function . Researchers should establish kinetic parameters (Km, Vmax) for comparison with literature values or human HTATIP2. The nuclear import inhibition function can be evaluated through in vitro nuclear import assays using fluorescently labeled import substrates and isolated nuclei or permeabilized cells . Western blot analysis comparing phosphorylation states of known downstream targets (like those in apoptotic pathways) in the presence and absence of recombinant HTATIP2 can confirm signaling functionality . A critical control experiment involves comparing wild-type HTATIP2 with site-directed mutants affecting the NAD binding domain to verify that observed effects depend on enzymatic activity. For studies focusing on HTATIP2's tumor suppressor function, cell-based proliferation and migration assays provide functional validation in a biological context.
HTATIP2 functions as a tumor suppressor with particular relevance to metastasis inhibition across multiple cancer types. In experimental cancer research, HTATIP2's proapoptotic and antiangiogenic properties make it an important target for therapeutic development . Cell line models for studying HTATIP2 in cancer should include both metastatic lines with low endogenous HTATIP2 expression (suitable for overexpression studies) and primary tumor lines with higher HTATIP2 levels (for knockdown approaches) . In breast cancer research specifically, MDA-MB-231T cells have been effectively used to demonstrate HTATIP2's interaction with dynamin (DNM2) and subsequent suppression of the EGF-EGFR signaling axis, ultimately inhibiting metastasis . Animal models for studying HTATIP2's in vivo effects include xenograft models with modulated HTATIP2 expression and orthotopic implantations that better recapitulate the metastatic process. Experimental design should incorporate both gain-of-function (using recombinant protein treatment or gene overexpression) and loss-of-function approaches (siRNA, CRISPR-Cas9) to comprehensively characterize HTATIP2's role in cancer progression or suppression.
Investigating HTATIP2-protein interactions in complex biological samples requires sophisticated biochemical and imaging techniques. Co-immunoprecipitation (Co-IP) has successfully demonstrated interactions between HTATIP2 and proteins like DNM2, confirming their physical association in cellular contexts . For improved specificity in complex lysates, proximity ligation assays (PLA) can visualize protein-protein interactions within intact cells with spatial resolution below 40 nm. To identify novel interaction partners, affinity purification coupled with mass spectrometry (AP-MS) using tagged recombinant HTATIP2 as bait represents the gold standard approach . For real-time interaction dynamics, fluorescence resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) between tagged HTATIP2 and potential partners provides valuable insights into interaction kinetics and subcellular localization. Researchers investigating redox-dependent interactions should perform experiments under controlled redox conditions, comparing NADPH-bound versus unbound states of HTATIP2 . Validation of identified interactions should include multiple complementary techniques and appropriate controls, such as mutated binding domains or competitive inhibition with peptide fragments.
HTATIP2 regulates nuclear import through its NADPH-bound form, which competitively inhibits nuclear import by binding to nuclear transport receptors . Studying this process requires specialized techniques that can visualize and quantify nuclear translocation events. Fluorescence recovery after photobleaching (FRAP) using GFP-tagged import substrates allows real-time measurement of import kinetics in living cells with or without recombinant HTATIP2 treatment . For biochemical assessment, in vitro nuclear import assays utilizing digitonin-permeabilized cells incubated with fluorescently labeled cargo proteins, cytosolic extracts, and various concentrations of recombinant HTATIP2 provide quantitative measurements of import inhibition . High-content imaging platforms can monitor nuclear accumulation of transcription factors regulated by HTATIP2 across multiple experimental conditions simultaneously. To directly assess HTATIP2's interaction with the nuclear transport machinery, pull-down assays using immobilized importins incubated with recombinant HTATIP2 in different NADPH-binding states reveal the specificity and affinity of these interactions . Structural studies employing hydrogen-deuterium exchange mass spectrometry (HDX-MS) or cryo-electron microscopy can further elucidate the conformational changes in HTATIP2 that mediate its interaction with nuclear transport receptors.
Post-translational modifications (PTMs) significantly impact HTATIP2's cellular functions, localization, and protein-protein interactions. Phosphorylation of HTATIP2 affects its protein kinase activity and ability to regulate programmed cell death . Mass spectrometry-based phosphoproteomics represents the most comprehensive approach for identifying phosphorylation sites, combining titanium dioxide enrichment of phosphopeptides with high-resolution MS/MS analysis. Site-directed mutagenesis of identified phosphorylation sites (converting serine/threonine to alanine or aspartate) allows functional validation of these modifications. Additionally, HTATIP2's redox-sensitive properties suggest potential regulation through oxidative modifications, which can be detected using redox proteomics approaches involving differential alkylation of free thiols before and after reduction . For ubiquitination analysis, tandem ubiquitin binding entity (TUBE) pull-downs followed by western blotting or MS analysis effectively enrich ubiquitinated forms of HTATIP2. Cell-based experiments should compare PTM patterns between normal and stress conditions (oxidative stress, hypoxia, nutrient deprivation) to understand how these modifications regulate HTATIP2's tumor suppressor functions. Researchers must consider species-specific differences in PTM patterns when translating findings between human and gorilla HTATIP2 studies.
HTATIP2's function as a redox sensor depends on critical structural elements that facilitate NADPH binding and subsequent conformational changes. X-ray crystallography studies have revealed that HTATIP2 contains an NAD-binding domain characteristic of short-chain dehydrogenase/reductase family proteins . Site-directed mutagenesis targeting the conserved NAD-binding motif (typically G-X-X-G-X-X-G) provides a powerful approach for identifying essential residues . Hydrogen-deuterium exchange mass spectrometry (HDX-MS) can map conformational changes that occur upon NADPH binding by measuring differences in hydrogen/deuterium exchange rates between bound and unbound states. For higher-resolution dynamic information, nuclear magnetic resonance (NMR) spectroscopy of isotopically labeled recombinant HTATIP2 can track chemical shift perturbations upon ligand binding. Circular dichroism (CD) spectroscopy complements these approaches by monitoring secondary structure changes in response to varying redox conditions. Functional validation should couple structural findings with biological assays, such as measuring nuclear import inhibition efficiency of mutant HTATIP2 proteins lacking key structural elements. Comparative analysis between human and gorilla HTATIP2 structures may reveal subtle differences in redox sensing mechanisms that have evolved between these closely related species.
Studying HTATIP2 isoforms presents significant challenges due to their structural similarity but distinct and sometimes opposing functions. Isoform 1 exhibits proapoptotic and antiangiogenic properties, while isoform 2 demonstrates antiapoptotic effects . To distinguish between isoforms in experimental settings, researchers must develop isoform-specific detection methods. Quantitative RT-PCR using primers spanning unique exon junctions provides accurate measurement of isoform-specific mRNA expression. For protein-level detection, custom antibodies targeting isoform-specific epitopes are essential, though cross-reactivity must be rigorously validated using recombinant protein standards of each isoform . Functional studies require isoform-specific expression constructs, ideally with inducible promoters to control expression levels. CRISPR-Cas9 genome editing targeting isoform-specific exons can generate cellular models expressing only one isoform. Differential interactome analysis using BioID or APEX proximity labeling coupled with mass spectrometry can reveal isoform-specific protein interaction networks. When designing experiments, researchers must consider that isoform expression ratios may vary between tissues and disease states, necessitating comprehensive profiling across multiple cellular contexts. The development of isoform-selective inhibitors remains a significant challenge but would represent a valuable tool for dissecting specific functions.
HTATIP2's interaction network includes several mitochondrial proteins involved in electron transport, suggesting an important role in mitochondrial function . To effectively study this aspect of HTATIP2 biology, researchers should employ multiple complementary approaches. Subcellular fractionation followed by western blotting can determine whether a portion of HTATIP2 localizes to mitochondria under specific cellular conditions . For higher-resolution localization, super-resolution microscopy or proximity ligation assays can visualize co-localization with known mitochondrial markers. Functional mitochondrial assays including oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements using platforms like Seahorse XF Analyzer can assess the impact of HTATIP2 modulation on mitochondrial respiration. Measurements of mitochondrial membrane potential (using JC-1 or TMRE dyes) and ROS production (using MitoSOX) in cells with altered HTATIP2 expression provide further insights into mitochondrial function. Blue native PAGE can identify whether HTATIP2 incorporates into respiratory chain supercomplexes. Stable isotope labeling with amino acids in cell culture (SILAC) followed by mitochondrial isolation and proteomics can comprehensively map changes in the mitochondrial proteome resulting from HTATIP2 manipulation. These approaches collectively will illuminate HTATIP2's role in mitochondrial biology beyond its established tumor suppressor functions.
Low expression or solubility of recombinant HTATIP2 represents a common challenge in research applications. To address expression issues, researchers should optimize codon usage for the expression host, particularly when expressing Gorilla gorilla gorilla sequences in heterologous systems . Lowering induction temperature (16-18°C) and reducing inducer concentration can improve soluble protein yield by slowing expression rate and allowing proper folding. For persistent solubility issues, fusion tags such as MBP (maltose-binding protein) or SUMO often prove more effective than standard His-tags for increasing solubility . Incorporating molecular chaperones (co-expression of GroEL/GroES for bacterial systems or PDI for eukaryotic systems) can significantly enhance proper folding. Optimization of lysis buffer composition is crucial - including 0.1-0.5% non-ionic detergents (Triton X-100 or NP-40), 5-10% glycerol, and 1-5 mM reducing agents (DTT or TCEP) typically improves HTATIP2 solubility . If inclusion bodies form despite these measures, solubilization and refolding protocols using gradient dialysis can recover active protein. Protein engineering approaches, such as surface entropy reduction or removal of hydrophobic patches through targeted mutations, may improve recombinant HTATIP2 properties while maintaining functional activity.
Antibody cross-reactivity and specificity issues frequently complicate HTATIP2 research, particularly when studying closely related species like humans and gorillas. To address these challenges, researchers should first validate commercial antibodies using positive controls (recombinant HTATIP2) and negative controls (HTATIP2-knockout cell lines generated through CRISPR-Cas9) . Epitope mapping helps identify antibodies targeting conserved versus variable regions between species. For western blotting applications, reducing background requires optimized blocking conditions (5% BSA often performs better than milk for phospho-specific antibodies) and extensive washing with detergent-containing buffers . The molecular weight verification is essential - HTATIP2 typically appears at 28-32 kDa, with possible additional bands representing isoforms or post-translationally modified variants . For immunoprecipitation, pre-clearing lysates and using protein A/G magnetic beads rather than agarose can reduce non-specific binding. When absolute specificity is required, generating custom monoclonal antibodies against species-specific epitopes represents the gold standard approach. For immunohistochemistry or immunofluorescence, antigen retrieval optimization and titration of primary antibody concentration are critical steps for reducing background while maintaining specific signal.
Rigorous experimental controls are essential when attributing cellular phenotypes to HTATIP2 activity. First, expression level controls must establish physiologically relevant HTATIP2 concentrations, as both overexpression artifacts and insufficient knockdown can lead to misleading results . Western blotting should confirm actual protein levels rather than relying solely on transcript measurements. Empty vector controls for overexpression studies and non-targeting siRNA/shRNA for knockdown experiments are mandatory negative controls . Positive controls might include known modulators of the pathway being studied (e.g., established apoptosis inducers when studying HTATIP2's proapoptotic functions). Rescue experiments represent the gold standard for specificity - phenotypes resulting from HTATIP2 knockdown should be reversible by reintroducing wild-type HTATIP2 but not catalytically inactive mutants . Time-course experiments help distinguish direct from indirect effects by revealing the temporal relationship between HTATIP2 modulation and observed phenotypes. Cell-type controls are equally important, as HTATIP2's effects may vary between cell types with different baseline expression levels or signaling contexts. For animal studies, littermate controls and blinded assessment of phenotypes are essential for minimizing bias and genetic background effects that might confound interpretation of HTATIP2-specific effects.
Single-cell technologies offer unprecedented opportunities to elucidate HTATIP2's function across heterogeneous cell populations within tissues. Single-cell RNA sequencing (scRNA-seq) can reveal cell type-specific expression patterns of HTATIP2 and its isoforms, potentially identifying previously unknown cellular niches where HTATIP2 plays critical roles . This approach is particularly valuable for understanding HTATIP2's differential effects in tumor microenvironments, where cancer cells, stromal cells, and immune populations may exhibit distinct HTATIP2 expression profiles and functions. Single-cell ATAC-seq (scATAC-seq) complements transcriptomic data by mapping chromatin accessibility changes in response to HTATIP2 modulation, illuminating its role in transcriptional regulation . For protein-level analysis, mass cytometry (CyTOF) with metal-conjugated anti-HTATIP2 antibodies enables simultaneous measurement of HTATIP2 expression alongside dozens of other proteins across thousands of individual cells. Spatial transcriptomics methods like Visium or MERFISH preserve tissue architecture information while providing HTATIP2 expression data, revealing potential correlation between HTATIP2 levels and specific tissue microenvironments. These approaches could substantially advance our understanding of how HTATIP2 contributes to tumor suppression in complex tissues and may reveal new therapeutic opportunities targeting HTATIP2-mediated pathways in specific cell populations.
CRISPR-based approaches offer powerful tools for dissecting HTATIP2 function with unprecedented precision. CRISPR-Cas9 knockout models provide clean genetic backgrounds for studying loss-of-function phenotypes, while CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) enable tunable repression or enhancement of endogenous HTATIP2 expression without overexpression artifacts . For studying specific domains or isoforms, CRISPR base editing or prime editing technologies allow introduction of specific amino acid changes or splice site modifications without double-strand breaks. CRISPR knock-in approaches can introduce fluorescent tags at the endogenous HTATIP2 locus, enabling live-cell imaging of HTATIP2 dynamics at physiological expression levels. Pooled CRISPR screens using HTATIP2 sgRNA libraries targeting different regions can identify functional domains critical for specific cellular phenotypes. Single-cell CRISPR screens combining genetic perturbation with transcriptomic readouts (CROP-seq) can reveal the gene regulatory networks downstream of HTATIP2 in various cellular contexts. For understanding tissue-specific functions, inducible CRISPR systems allowing temporal and spatial control of HTATIP2 editing in animal models would provide valuable insights into its role in development and disease progression in vivo.
Advanced structural biology techniques promise to revolutionize our understanding of HTATIP2's molecular mechanisms. Cryo-electron microscopy (cryo-EM) can visualize HTATIP2 in complex with its interaction partners like nuclear transport receptors, potentially capturing different conformational states during the nuclear import regulation process . AlphaFold2 and other AI-based structure prediction tools can generate high-confidence models of Gorilla HTATIP2, allowing comparison with human structures to identify subtle species-specific differences. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) provides dynamic information about which regions of HTATIP2 undergo conformational changes upon NADPH binding or interaction with partner proteins . Time-resolved X-ray crystallography or time-resolved cryo-EM could potentially capture transient states during HTATIP2's catalytic cycle. For studying redox-dependent structural changes, electron paramagnetic resonance (EPR) spectroscopy combined with site-directed spin labeling can measure distances between specific residues under different redox conditions. Integrative structural biology approaches combining multiple techniques (crystallography, NMR, SAXS, computational modeling) would provide the most comprehensive view of HTATIP2 structure-function relationships. These structural insights could guide rational design of small molecules that modulate HTATIP2 activity for research tools or potential therapeutic applications targeting its tumor suppressor functions.